Hovione Completes Initial $100M Investment Cycle to Expand U.S. Operations at New Jersey Manufacturing Site
Innovations in Pharmaceutical Technology, IPT Online, 27 October 2025
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Innovations in Pharmaceutical Technology, IPT Online, 27 October 2025
Hovione, the global leader in spray drying and particle engineering, today announced that it is expanding its industrial facilities around the world to support its ambitious growth objectives
Hovione is closer to its customers with a new website in Mandarin
Hovione offers simple, patented and globally competitive dry powder inhalers – Disposable, Capsule, Blister and Large Dose DPIs – which are available for fully integrated turn-key development with formulation and for licensing.
Hovione won the 2023 CDMO Leadership Award across all six categories across all three groups of respondents
Investment in Hovione Tejo will expand industrial capacity and strengthen the company’s global leadership in spray drying and other advanced pharmaceutical manufacturing technologies.
Safety First, Quality Always: We are continuously improving the safety of our operations with the patient’s safety in mind.